News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current CSTL market cap is 533.64M. The company's latest EPS is USD -2.4949 and P/E is -7.93.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 34.84M | 55M | 38.64M | 42.04M | 50.14M |
| Operating Income | -24.37M | -3.7M | -22.83M | -31.52M | -21.16M |
| Net Income | -1.65M | -20.25M | -20.62M | -29.2M | -18.78M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 22.79M | 51.87M | 64.53M | 94.09M | 155.33M |
| Operating Income | -3.84M | 7.33M | -6.54M | -40.08M | -72.86M |
| Net Income | -10.16M | 2.99M | -10.28M | -31.29M | -67.14M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 458.38M | 457.81M | 447.33M | 426.89M | 425.4M |
| Total Liabilities | 36.72M | 46.38M | 48.18M | 41.74M | 46.63M |
| Total Equity | 421.66M | 411.43M | 399.15M | 385.15M | 378.77M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 22.41M | 119.75M | 439.33M | 462.57M | 447.33M |
| Total Liabilities | 32.47M | 34.63M | 23.64M | 50.83M | 48.18M |
| Total Equity | -56.57M | 85.11M | 415.69M | 411.74M | 399.15M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -30.43M | -35.66M | -41.66M | -25.44M | -29.23M |
| Investing | -27.91M | -162.06M | -166.55M | 16.58M | 1.2M |
| Financing | 1.88M | 2.27M | 1.52M | 728k | 954k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.3M | 7.02M | 9.87M | -18.98M | -41.66M |
| Investing | -277k | -937k | -4.75M | -66.66M | -166.55M |
| Financing | 15.84M | 88.29M | 305.89M | 5.42M | 1.52M |
| Market Cap | 533.64M |
| Price to Earnings Ratio | -7.93 |
| Price to Sales Ratio | 3.43 |
| Price to Cash Ratio | 4.33 |
| Price to Book Ratio | 1.33 |
| Dividend Yield | - |
| Shares Outstanding | 26.91M |
| Average Volume (1 week) | 221.15k |
| Average Volume (1 Month) | 212.97k |
| 52 Week Change | -22.45% |
| 52 Week High | 29.59 |
| 52 Week Low | 9.2601 |
| Spread (Intraday) | 0.8 (3.95%) |
| Company Name | Castle Biosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.castlebiosciences.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
